Search
for
Sort by
Research 91–120 of 1000+
- ANIFROLUMAB IN THE MANAGEMENT OF LUPUS HEADACHES: A CASE REPORT
- Platelet Immune Interactions, Lifespan, and Senescence
- NF-κB in biology and targeted therapy: new insights and translational implications
- Targeted Treatments of Non-Small Cell Lung Cancer (NSCLC): Skin Toxicity
- PO.8.170 Drug-induced lupus or systemic lupus erythematosus after experimental COVID-19 therapy: difficulties in differential diagnosis
- Global Impact of Coronavirus Disease 2019 (COVID-19)
- LB793 A phase 1, open-Label, single ascending dose study in healthy subjects of the safety, tolerability and pharmacokinetics of ASLAN004, a novel IgG anti-IL-13 receptor alpha 1 Inhibitor
- Hair Growth in a Patient with Alopecia Areata on Tocilizumab
- Severe scarring alopecia associated with combinational use of ficlatuzumab and gefitinib: a clinical and immunohistochemistry study
- X-linked Recessive Ectodysplasin A Mutations Induced Hypohidrotic Ectodermal Dysplasia and Severe Atopic Dermatitis Successfully Treated with Dupilumab
- Editorial: Prevention and treatment of skin diseases
- A case of dupilumab-induced psoriatic alopecia
- Revolutionizing psoriasis care: Microneedle innovations in treatment and diagnosis
- BI35 A case of dupilumab-induced scalp psoriasis and review of the literature
- BH22 Alopecia areata caused by an adverse reaction to denosumab
- Successful Treatment of Adalimumab-Induced Paradoxical Skin Reactions in Pustulotic Arthro-Osteitis With Guselkumab
- Drug-Induced Hair Loss: Analysis of the Food and Drug Administration’s Adverse Events Reporting System Database
- Editorial: Targeted immunological therapies in dermatology
- Aim to alleviate alopecia areata with newly available agents
- Pharmacotherapy for Keloids and Hypertrophic Scars
- Efficacy of Dupilumab in Treating Atopic Dermatitis With Recurrent Eczema Herpeticum in a Patient With DOCK8-Deficiency Hyper-IgE Syndrome: A Case Report
- BH14 Multiple sclerosis and alopecia areata: drug-induced alopecia areata or coexisting autoimmune phenomena?
- Data from Tumor Necrosis Factor-α and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice
- Data from Tumor Necrosis Factor-α and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice
- Cutaneous Lupus Erythematosus
- Evaluation of the Hemogram of Breast Cancer Patients Treated by Therapeutic Protocol Based on Immunohistochemical Analysis: A Retrospective Study
- Skin fragility, diffuse ecchymosis and blisters on a yellowish waxy base
- Faculty Opinions recommendation of Loss of desmocollin 3 in mice leads to epidermal blistering.
- Epithelial cell migration on laminins
- 8. Pathology